ArticleFrontiers in oncology2023
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.
Anamaris Torres-Sanchez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it